title: Pharmacokinetic interactions between clopidogrel and rosuvastatin: effects on vascular protection in subjects with coronary heart disease.
authors.forename: Luiz F
authors.initials: LF
authors.lastname: Pinheiro
authors.forename: Carolina N
authors.initials: CN
authors.lastname: França
authors.forename: Maria C
authors.initials: MC
authors.lastname: Izar
authors.forename: Simone P
authors.initials: SP
authors.lastname: Barbosa
authors.forename: Henrique T
authors.initials: HT
authors.lastname: Bianco
authors.forename: Soraia H
authors.initials: SH
authors.lastname: Kasmas
authors.forename: Gustavo D
authors.initials: GD
authors.lastname: Mendes
authors.forename: Rui M
authors.initials: RM
authors.lastname: Povoa
authors.forename: Francisco A H
authors.initials: FA
authors.lastname: Fonseca
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control; D000077144:Clopidogrel; D003327:Coronary Disease / Q000150:complications; D004347:Drug Interactions; D005260:Female; D005464:Fluorobenzenes / Q000493:pharmacokinetics*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000493:pharmacokinetics*; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000493:pharmacokinetics*; D011743:Pyrimidines / Q000493:pharmacokinetics*; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000493:pharmacokinetics*; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics
chemical_list: D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium; D000077144:Clopidogrel; D013988:Ticlopidine